Actively Recruiting

Phase Not Applicable
Age: 25Years - 49Years
FEMALE
NCT07177170

Impact of a Single Versus Multiple Visits on the Cervical Cancer Screening Completeness, Feasibility and Acceptability Among Women Living With HIV in Cameroon

Led by Institut de Recherche pour le Developpement · Updated on 2025-09-16

1422

Participants Needed

1

Research Sites

124 weeks

Total Duration

On this page

Sponsors

I

Institut de Recherche pour le Developpement

Lead Sponsor

E

Ecole Polytechnique Fédérale de Lausanne

Collaborating Sponsor

AI-Summary

What this Trial Is About

Context. Cervical cancer (CC) is a leading cause of death among women living with HIV (WLHIV) in resource-limited settings. Yet, effective methods for screening and preventing CC are available. The recommanded approach for CC screening is based on multiple steps, including initial test to detect human papillomavirus (HPV) infection, visual inspection to identify women with HPV at risk for precancerous lesion and treatment when required. Dropout may occur at these different steps, compromising the success of the CC elimination strategy. Performing the all screening and treatment sequence in a single visit has been recommanded based on the results of a large South African trial. Yet, in many contexts, including those with limited resources, the screening and treatment activities are performed in multiple visites for logistical reasons, resulting in many dropouts. Strategies based on the differentiated prestation approaches, which propose a simplified management centered on the patients preferences, could guide the adaptation of the single-visit approach to account for contextual constraints while maintaining high effectiveness. The OptiTri-GC study aims to design and assess the impact of a differentiated CC screen and treat strategy in a district hospital; It will assess both its implementation and its effectiveness based on the completeness at each stage of the screening cascade. In addition, it will also include three sub-studies designed to evaluate : * The performance of urinary HPV testing. * The performance of different methods to identify women requiring a treatment. * The risk of post-treatment cervical disease. This study has two periods. During the first period, a single visit approach will be used while differentiated approach will be prepared using participatory research. During the second period, the differentiated approach will be implemented. The screening overall completeness will be compared between the two periods to assess the differentiated approach effectiveness. The study will also assess the implementation of each screening strategy in terms of : * Success through the measure of fidelity, reach and completeness * Identification of adaptation, barriers and facilitating/leverage factors * Perception, feasibility and acceptability of the screening strategies (by patients and health care workers) It will assess the participants' stress levels during the screening process and to identify potential psychosocial support strategies and document the experience of WLHIV and health workers during the screening process and the post-treatment follow-up. Other study objectives include : * To assess the performance of different methods to identify women requiring a treatment * To assess the performance of HPV testing on a urine sample compared with vaginal self-collected or cervical (clinician-collected) samples * To assess the efficacy of treatment in terms of post-treatment cervical lesions Methodology. Participants will be WLHIV aged 25 to 49 and eligible for CC screening. Health care workers will also be invited to participate to the implementation research. The data collected will be quantitative and qualitative.

CONDITIONS

Official Title

Impact of a Single Versus Multiple Visits on the Cervical Cancer Screening Completeness, Feasibility and Acceptability Among Women Living With HIV in Cameroon

Who Can Participate

Age: 25Years - 49Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • HIV infection
  • Receiving antiretroviral therapy
  • Living in the department of the study hospital
  • Aged between 25 and 49 years
  • Eligible for cervical cancer screening
Not Eligible

You will not qualify if you...

  • Ongoing pregnancy
  • History of hysterectomy
  • Treatment of cervical lesion in the past 12 months
  • Expected follow-up difficulties (e.g., planned travel, relocation, transfer)
  • Any condition or treatment that prevents satisfactory participation as judged by investigators
  • Menstrual bleeding at time of inclusion
  • Post-partum period less than 12 weeks after delivery
  • Clinical signs of cervical or pelvic infection

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Foumban hospital

Foumban, Cameroon

Actively Recruiting

Loading map...

Research Team

A

Andre-Pascal Goura, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

SEQUENTIAL

Primary Purpose

SCREENING

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here